TY  - CONF
AU  - Riesco Martinez, M. C.
AU  - Capdevila, J.
AU  - Alonso, V.
AU  - Teule, A.
AU  - Grande, E.
AU  - Jimenez-Fonseca, P.
AU  - Benavent, M.
AU  - Alonso Gordoa, T.
AU  - Custodio, A.
AU  - Hierro Carbo, C.
AU  - Lopez, C.
AU  - Sevilla Garcia, I.
AU  - Garcia-Carbonero, R.
PY  - 2020
DO  - 10.1016/j.annonc.2020.08.2092
SN  - 0923-7534
UR  - https://hdl.handle.net/10668/26986
T2  - Annals of oncology
LA  - en
PB  - Elsevier
TI  - NICE-NEC, a phase II study of platinum-doublet chemotherapy in combination with nivolumab as first-line treatment in subjects with unresectable, locally advanced or metastatic grade 3 neuroendocrine neoplasms (NENs) of the gastroenteropancreatic tract or of unknown origin. GETNE-T1913
TY  - conference output
VL  - 31
ER  -